WANG Shen-ming, YIN Heng-hui, LI Xue-rui. Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinome[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 77-80. DOI: 10.3969/j.issn.1671-5144.2006.02.004
|
Citation:
|
WANG Shen-ming, YIN Heng-hui, LI Xue-rui. Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinome[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 77-80. DOI: 10.3969/j.issn.1671-5144.2006.02.004
|
WANG Shen-ming, YIN Heng-hui, LI Xue-rui. Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinome[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 77-80. DOI: 10.3969/j.issn.1671-5144.2006.02.004
|
Citation:
|
WANG Shen-ming, YIN Heng-hui, LI Xue-rui. Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination with Paclitaxel for the Treatment of HER-2 Positive Metastatic Breast Carcinome[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 77-80. DOI: 10.3969/j.issn.1671-5144.2006.02.004
|
DownLoad: